Drugs / MTX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04547049 Comparator | Sep 2020 → Apr 2026 overdue | leukemia, myelodysplastic syndrome | First Affiliated Hospital of Zhejiang University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04547049 ↗ |
| Route | Intravenous | “administered intravenously” NCT04547049 ↗ |